Episodic dural stimulation in awake rats: A model for recurrent headache

Headache

Volumn 47, Issue 7, 2007, Pages 1026-1036

  Oshinsky, Michael L ^a   Gomonchareonsiri, Sumittra ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b Faculty of Medicine Chiang Mai University   (Thailand)

Author keywords

Chronic daily headache; Dura; Inflammation; Microdialysis; Migraine; Pain; Pathophysiology; Sensory testing

Indexed keywords

GLUTAMIC ACID; GLYCEROL NITRATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CANNULA; CONTROLLED STUDY; HEADACHE; HYPERSENSITIVITY; IN VIVO STUDY; MALE; MICRODIALYSIS; MIGRAINE; NERVE STIMULATION; NOCICEPTIVE RECEPTOR; NONHUMAN; PRIORITY JOURNAL; RAT; SENSORY SYSTEM EXAMINATION; WAKEFULNESS;

AMINO ACIDS; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; DURA MATER; HEADACHE; INFLAMMATION; MALE; MICRODIALYSIS; MIGRAINE DISORDERS; RATS; RATS, SPRAGUE-DAWLEY; TOUCH; TRIGEMINAL NERVE;

EID: 34447315526     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2007.00871.x     Document Type: Article

References (54)

1. Reuter U, Bolay H, Jansen-Olesen I, et al Delayed inflammation in rat meninges: Implications for migraine pathophysiology. Brain. 2001 124 : 2490 2502.
2. Goadsby PJ. Recent advances in understanding migraine mechanisms, molecules and therapeutics. Trends Mol Med. 2007 13 : 39 44.
3. Burstein R, Jakubowski M. Unitary hypothesis for multiple triggers of the pain and strain of migraine. J Comp Neurol. 2005 493 : 9 14.
4. Burstein R, Jakubowski M, Levy D. Anti-migraine action of triptans is preceded by transient aggravation of headache caused by activation of meningeal nociceptors. Pain. 2005 115 : 21 28.
5. Bolay H, Reuter U, Dunn AK, Huang Z, Boas DA, Moskowitz MA. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med. 2002 8 : 136 142.
6. Reuter U, Bolay H, Jansen-Olesen I, et al Delayed inflammation in rat meninges: Implications for migraine pathophysiology. Brain. 2001 124 : 2490 2502.
7. Giamberardino MA. Referred muscle pain/hyperalgesia and central sensitisation. J Rehabil Med. 2003 41 Suppl. 85 88.
8. Bolay H, Moskowitz MA. Mechanisms of pain modulation in chronic syndromes. Neurology. 2002 59 (5 Suppl. 2 S2 S7.
9. Laird JM, Martinez-Caro L, Garcia-Nicas E, Cervero F. A new model of visceral pain and referred hyperalgesia in the mouse. Pain. 2001 92 : 335 342.
10. Piovesan E, Young B, Werneck L, Kowacs P, Oshinsky M, Silberstein S. Recurrent extratrigeminal stabbing and burning sensation with allodynia in a migraine patient. Cephalalgia. 2003 23 : 231 234.
11. Woolf CJ, Salter MW. Neuronal plasticity: Increasing the gain in pain. Science. 2000 288 : 1765 1768.
12. Dubner R. Plasticity in central nociceptive pathways. In : Merskey H, Loeser JD, Dubey R, eds. The Paths of Pain 1975-2005. Seattle, WA : IASP Press 2005 : 101 115.
13. Strassman AM, Raymond SA, Burstein R. Sensitization of meningeal sensory neurons and the origin of headaches. Nature. 1996 384 : 560 564.
14. Strassman AM, Levy D. Response properties of dural nociceptors in relation to headache. J Neurophysiol. 2006 95 : 1298 1306.
15. Ashina M, Simonsen H, Bendtsen L, Jensen R, Olesen J. Glyceryl trinitrate may trigger endogenous nitric oxide production in patients with chronic tension-type headache. Cephalalgia. 2004 24 : 967 972.
16. Olesen J, Thomsen LL, Iversen H. Nitric oxide is a key molecule in migraine and other vascular headaches. Trends Pharmacol Sci. 1994 15 : 149 153.
17. Thomsen LL, Kruuse C, Iversen HK, Olesen J. A nitric oxide donor (nitroglycerin) triggers genuine migraine attacks. Eur J Neurol. 1994 1 : 73 80.
18. Sances G, Tassorelli C, Pucci E, Ghiotto N, Sandrini G, Nappi G. Reliability of the nitroglycerin provocative test in the diagnosis of neurovascular headaches. Cephalalgia. 2004 24 : 110 119.
19. Dalsgaard-Nielsen T. Migraine diagnostics with special reference to pharmacological tests. Int Arch Allergy Immunol. 1955 7 : 312 322.
20. Olesen J, Iversen HK, Thomsen LL. Nitric oxide supersensitivity: A possible molecular mechanism of migraine pain. NeuroReport. 1993 4 : 1027 1030.
21. Sarchielli P, Alberti A, Codini M, Floridi A, Gallai V. Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks. Cephalalgia. 2000 20 : 907 918.
22. Woolf CJ, Thompson SW. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain. 1991 44 : 293 299.
23. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991 43 : 109 142.
24. Offenhauser N, Zinck T, Hoffmann J, et al CGRP release and c-fos expression within trigeminal nucleus caudalis of the rat following glyceryltrinitrate infusion. Cephalalgia. 2005 25 : 225 236.
25. Costa A, Smeraldi A, Tassorelli C, Greco R, Nappi G. Effects of acute and chronic restraint stress on nitroglycerin-induced hyperalgesia in rats. Neurosci Lett. 2005 383 : 7 11.
26. Jones MG, Lever I, Bingham S, Read S, McMahon SB, Parsons A. Nitric oxide potentiates response of trigeminal neurons to dural or facial stimulation in the rat. Cephalalgia. 2001 21 : 643 655.
27. Strecker T, Dux M, Messlinger K. Nitric oxide releases calcitonin-gene-related peptide from rat dura mater encephalic promoting increases in meningeal blood flow. J Vasc Res. 2002 39 : 489 496.
28. Kitto KF, Haley JE, Wilcox GL. Involvement of nitric oxide in spinally mediated hyperalgesia in the mouse. Neurosci Lett. 1992 148 : 1 5.
29. Aley KO, McCarter G, Levine JD. Nitric oxide signaling in pain and nociceptor sensitization in the rat. J Neurosci. 1998 18 : 7008 7014.
30. Ramadan NM, Olesen J. Classification of headache disorders. Semin Neurol. 2006 26 : 157 162.
31. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 1994 53 : 55 63.
32. Vos BP, Strassman AM, Maciewicz RJ. Behavioral evidence of trigeminal neuropathic pain following chronic constriction injury to the rat's infraorbital nerve. J Neurosci. 1994 14 : 2708 2723.
33. Oshinsky ML, Luo J. Neurochemistry of trigeminal activation in an animal model of migraine. Headache. 2006 46 (Suppl. 1 S39 S44.
34. Biondi DM. Is migraine a neuropathic pain syndrome? Curr Pain Headache Rep. 2006 10 : 167 178.
35. Cooke L, Eliasziw M, Becker WJ. Cutaneous allodynia in transformed migraine patients. Headache. 2007 47 : 531 539.
36. Malick A, Jakubowski M, Elmquist JK, Saper CB, Burstein R. A neurohistochemical blueprint for pain-induced loss of appetite. Proc Natl Acad Sci U S A. 2001 98 : 9930 9935.
37. Bergerot A, Holland PR, Akerman S, et al Animal models of migraine: Looking at the component parts of a complex disorder. Eur J Neurosci. 2006 24 : 1517 1534.
38. Goadsby PJ, Classey JD. Evidence for serotonin (5-HT)1B, 5-HT1D and 5-HT 1F receptor inhibitory effects on trigeminal neurons with craniovascular input. Neuroscience. 2003 122 : 491 498.
39. Goadsby PJ, Duckworth JW. Low frequency stimulation of the locus coeruleus reduces regional cerebral blood flow in the spinalized cat. Brain Res. 1989 476 : 71 77.
40. Bigal ME, Lipton RB. When migraine progresses: Transformed or chronic migraine. Exp Rev Neurother. 2006 6 : 297 306.
41. Ferrari A, Leone S, Vergoni AV, et al Similarities and differences between chronic migraine and episodic migraine. Headache. 2007 47 : 65 72.
42. Buchgreitz L, Lyngberg AC, Bendtsen L, Jensen R. Frequency of headache is related to sensitization: A population study. Pain. 2006 123 : 19 27.
43. Kropp P, Linstedt U, Gerber W. Duration of migraine disease correlates with amplitude and habituation of event-related potentials. Schmerz. 2005 19 : 489 496.
44. Loder E, Biondi D. General principles of migraine management: The changing role of prevention. Headache. 2005 45 (Suppl. 1 S33 S47.
45. Katsarava Z, Schneeweiss S, Kurth T, et al Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology. 2004 62 : 788 790.
46. Limmroth V, Biondi D, Pfeil J, Schwalen S. Topiramate in patients with episodic migraine: Reducing the risk for chronic forms of headache. Headache. 2007 47 : 13 21.
47. Silberstein SD, Saper JR, Freitag FG. Migraine: Diagnosis and treatment. In : Silberstein S, Lipton RB, Dalessio, eds. Wolff's Headache and Other Head Pain. New York : Oxford University Press, 2001 121 237.
48. Pardutz A, Szatmári E, Vecsei L, Schoenen J. Nitroglycerin-induced nNOS increase in rat trigeminal nucleus caudalis is inhibited by systemic administration of lysine acetylsalicylate but not of sumatriptan. Cephalalgia. 2004 24 : 439 445.
49. Van Der Kuy P-M, Lohman JJHM. The role of nitric oxide in vascular headache. Pharm World Sci. 2003 25 : 146 151.
50. Ramadan NM. The link between glutamate and migraine. CNS Spectr. 2003 8 : 446 449.
51. Christiansen I, Thomsen LL, Daugaard D, Ulrich V, Olesen J. Glyceryl trinitrate induces attacks of migraine without aura in sufferers of migraine with aura. Cephalalgia. 1999 19 : 660 667.
52. Vincent V. GTN in migraine. Cephalalgia. 1999 19 : 626.
53. Kemper RHA, Meijler WJ, Ter Horst GJ. Trigeminovascular stimulation in conscious rats. NeuroReport. 1997 8 : 1123 1126.
54. Ter Horst GJ, Meijler WJ, Korf J, Kemper RHA. Trigeminal nociception-induced cerebral fos expression in the conscious rat. Cephalalgia. 2001 21 : 963 975.